The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Molecular basis of the Keap1–Nrf2 system
Open accessAbstract
Nrf2 (NF-E2-related factor 2) is a master regulator of cellular responses against environmental stresses. Nrf2 induces the expression of detoxification and antioxidant enzymes, and Keap1 (Kelch-like ECH-associated protein 1), an adaptor subunit of Cullin 3-based E3 ubiquitin ligase, regulates Nrf2 activity. Keap1 also acts as a sensor for oxidative and electrophilic stresses. Keap1 retains multiple sensor cysteine residues that detect various stress stimuli. Increasing attention has been paid to the roles that Nrf2 plays in the protection of our bodies against drug toxicity and stress-induced diseases. On the other hand, Nrf2 is found to promote both oncogenesis and cancer cell resistance against chemotherapeutic drugs. Thus, although Nrf2 acts to protect our body from deleterious stresses, cancer cells hijack the Nrf2 activity to support their malignant growth. Nrf2 has emerged as a new therapeutic target, and both inducers and inhibitors of Nrf2 are awaited. Studies challenging the molecular basis of the Keap1-Nrf2 system functions are now critically important to improve translational studies of the system. Indeed, recent studies identified cross talk between Nrf2 and other signaling pathways, which provides new insights into the mechanisms by which the Keap1-Nrf2 system serves as a potent regulator of our health and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The transcription factor Nrf2 is considered as a redox switch regulating the expression of antioxidant enzymes, GSH-synthesizing enzymes, and detoxifying Phase 2 enzymes (175), while the specific selenocysteine tRNA is needed for the synthesis of selenoproteins such as GPx or Trx reductase, which reduces oxidized Trx (133) (Fig. 2).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [175]
Citations
Cites
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Self-citationKomatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288
Self-citationOncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova‐Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,210
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Self-citationNrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725
Self-citationZhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395
Self-citation
Cited by
Sorted by citations
Items 901–997 of 997
Wang, G., Garcia, V., Lee, J., Yanum, J. A., Jiang, H., & Dai, G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.26.441515
Zhang, H., Ma, Y., Wang, M., Elsabagh, M., & Wang, H. (2020) · doi:10.21203/rs.3.rs-95710/v1
Suprihatin, T., Rahayu, S., Rifa’i, M., & Widyarti, S. (2020) · Buletin Anatomi dan Fisiologi · doi:10.14710/baf.5.2.2020.190-197
Yildiz, M., & Seğmen, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102753
Sedik, A. A., & Amer, A. A. (2022) · Research Square · doi:10.21203/rs.3.rs-1328467/v2
Extension of Healthy Life Span of Dialysis Patients in the Era of a 100-Year Life
Inaba, M., & Mori, K. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-2345-3
Lipton, S. A. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726273509.793538961
Fisher, P. B., & Emdad, L. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736054359.793562930
(2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803013-4.00018-1
Conjugation and Transport Processes
Coleman, M. D. (2020) · Wiley eBooks · doi:10.1002/9781119658016.ch6
Ding, X., & Zhang, Q.-Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95619-8
Gomes, C. J. C. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2021.tde-17012022-123152
Autophagy in the Intestinal Stem Cells
Göncü, E. (2022) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-17362-2_7
Gutsenko, O. I., Корниенко, И. В., Ananyan, A. A., Milutina, N. P., & Внуков, В. В. (2022) · Russian Journal of Biological Physics and Chemisrty · doi:10.29039/rusjbpc.2022.0569
Paola, R. D., Cuzzocrea, S., Fusco, R., & Cordaro, M. (2023) · Biochemistry · doi:10.5772/intechopen.109239
Akın, D. F., & Aktaş, S. H. (2023) · Namık Kemal Tıp Dergisi · doi:10.4274/nkmj.galenos.2023.74745
The role of NRF-2 in renal damage in cardiopulmonary bypass
Padak, M. (2023) · Eurasian Clinical and Analytical Medicine · doi:10.4328/ecam.10038
Villavicencio-Tejo, F., & Quintanilla, R. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90052-2.00003-2
Intestinal redox regulation and inflammatory bowel disease
Iwaki, H., & Motohashi, H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19247-0.00015-1
Targeting the NF-E2-related factor 2 pathway for overcoming leukemia
Harifi-Mood, M. S., Daroudi, M., Darroudi, M., Naseri, K., Samarghandian, S., & Farkhondeh, T. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127594
Iron Metabolism and Ferroptosis
Zheng, H., & Toyokuni, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-39171-2_2
Yuan, J., Gao, H., Zhou, D., Wang, Y., Shen, F., Chen, Y., & Zhu, R. (2023) · Natural Product Communications · doi:10.1177/1934578x231214129
Progress of Itaconate in the Treatment of Renal Diseases
曹, 心. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142322
NRF2'nin İkili Doğası: Kanser Gelişiminde Koruyucu ve Teşvik Edici Rolü
Kaleler, İ., & Yaylım, İ. (2024) · Haliç Üniversitesi Fen Bilimleri Dergisi · doi:10.46373/hafebid.1442953
Ji-hao, G., Lei, X., Wang, X., Yang, Z., Lin, L., Zhu, W., Li, S., & Chen, Y. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4776055
Teng, X., Yang, Y., Chen, Z., Wang, J., Wang, X., Zheng, Y., Wang, C., Wang, Y., Zhu, Z., Ding, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23812634
The induction of metallothionein by sulforaphane reduces iron toxicity via Nrf2
Elvandari, A. P., Siswanto, F. M., & Imaoka, S. (2024) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2024.193124
Mateos, R. N., Winardi, W., Chiba, K., Okada, A., Suzuki, A., Mitsuishi, Y., & Shiraishi, Y. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00475-w
Bai, L., Jiang, Y., Li, X., Yu, W., Zhu, W., Zhao, G., Yang, T., Zhou, Y., Li, J., & Li, Y. (2025) · Journal of Veterinary Research · doi:10.2478/jvetres-2025-0018
Li, H., Liu, R., Kathamuthu, G. R., Gencheva, R., Scholz, A.-L., Alzrigat, M., Coppo, L., Arnér, E. S. J., & Rottenberg, M. E. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5240783
Tau, S. S., Friedman, M., Roberts, A. M., Ferridge, L. R., Kleist, S. A., Cressey, L. E., Kettenbach, A. N., Shoemaker, C. J., & Miller, T. W. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.18.665614
Srimuang, K., Buakaew, W., Thongsri, Y., Daowtak, K., Potup, P., Ferrante, A., & Usuwanthim, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188911
Georgiou‐Siafis, S. K., & Kotsi, P. (2025) · Receptors · doi:10.3390/receptors4040021
Li, M., & Li, J. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70610
Transcription factor NRF2: New therapeutic approach to modify Parkinson's disease progression
Rojo, A. I., Esteras, N., Cuadrado, A., & Lastres‐Becker, I. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-21992-4.00025-7
Regulome-SNP and Novel Risk Markers of CHD Susceptibility in the Yanbian AreaPreprint
Yang, E., Jin, X., Liu, X., Dong, C.-Y., Cai, W.-X., Sun, S.-Y., Sun, Z., Li, Y.-Z., Jin, J., & Jin, G. (2025) · Research Square · doi:10.21203/rs.3.rs-7698288/v1
Baig, N., Sultan, R., & Qureshi, S. A. (2022) · Figshare · doi:10.6084/m9.figshare.21602004
Baig, N., Sultan, R., & Qureshi, S. A. (2022) · Figshare · doi:10.6084/m9.figshare.21602001
Xu, T., Yang, Y., Chen, Z., Wang, J., Wang, X., Zheng, Y., Wang, C., Wang, Y., Zhu, Z., Ding, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23812640
Zhang, Q., Cheng, X., Zhang, H., Zhang, T., Wang, Z., Zhang, W., & Yu, W. (2020) · Figshare · doi:10.6084/m9.figshare.13357940
Da'as, S. I., Ahmed, I., Hasan, W., Abdelrahman, D., ALIYEV, E. E., Nisar, S., Bhat, A. A., Joglekar, M. V., Hardikar, A. A., Fakhro, K. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26572801
Zhang, A., Li, H., Song, Q., Cui, Y., Zhang, Y., Wang, X., Li, Z., & Hou, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24515851
Xia, D., Zhang, X.-R., Ma, Y.-L., Zhao, Z.-J., Zhao, R., & Wang, Y.-Y. (2020) · Figshare · doi:10.6084/m9.figshare.12744138
Xu, T., Yang, Y., Chen, Z., Wang, J., Wang, X., Zheng, Y., Wang, C., Wang, Y., Zhu, Z., Ding, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23812637
Xu, T., Yang, Y., Chen, Z., Wang, J., Wang, X., Zheng, Y., Wang, C., Wang, Y., Zhu, Z., Ding, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23812643
Zhang, A., Li, H., Song, Q., Cui, Y., Zhang, Y., Wang, X., Li, Z., & Hou, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26636565
Zhang, A., Li, H., Song, Q., Cui, Y., Zhang, Y., Wang, X., Li, Z., & Hou, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26636562
Zhang, A., Li, H., Song, Q., Cui, Y., Zhang, Y., Wang, X., Li, Z., & Hou, Y. (2024) · Figshare · doi:10.6084/m9.figshare.24516103
Investigating gender differences in Alzheimer's disease
Fouad, G. I., Ando, H., & Ichihara, G. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251410204 · Cited by 2
Diacerein protects against Ovariectomy-Induced bone loss via reversal of NRF2 epigenetic suppression
Qiao, L., Shen, T., Ben, Y., Dong, J., Liu, B., Chen, X., & Jiang, Q. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117748
Augmenting Nrf2 signaling pathway promotes adipocyte differentiation from human embryonic stem cells
Park, M. H., Gil, D., Han, H., & Kim, J.-H. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114917
Lee, S., Ali, A. R., Abed, D. A., & Hu, L. (2026) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2026.2622777
ROS-Mediated Cellular Signaling Pathways in Metabolic Disorders
Gunasekaran, S. K., Gobinath, M., Roychowdhury, P., Maideen, N. M. P., & Kuppusamy, G. (2026) · Springer eBooks · doi:10.1007/978-3-032-11752-6_4
Zhang, X., Zhang, Q.-M., Xia, L.-B., Ge, K., Talukder, M., She, D.-Y., & Bi, S.-S. (2026) · Biological Trace Element Research · doi:10.1007/s12011-026-05038-0
Enhancing Tumour Radiosensitivity by Targeting Nrf2 Antioxidant System
Golyshev, G., Tikunova, K. V., Deeni, Y., & Goltsov, A. N. (2026) · Medical Radiology and radiation safety · doi:10.33266/1024-6177-2026-71-5-20-32
Mi, Y., Wang, R., Qian, J., Liu, Z., Li, Y., Fan, H., Wang, L., Kuai, H., Xiong, F., Wang, H., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158147
A Hetero-multivalent Covalent Strategy for Enhanced Pulmonary Fibrosis TherapyPreprint
Ge, G., Zhu, G., Deng, Y., Wu, H., Zhang, H., Zhu, G., Zeng, H., Li, N., Wang, L., Fan, Y., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9244913/v1
Zou, Y., Peng, H., Huang, C., Zhou, B., Huang, K., Zhang, Y., Gu, J., Li, X. D., Zhu, T., Zhao, W., et al. (2026) · Aquaculture Reports · doi:10.1016/j.aqrep.2026.103609
Zhang, Y., He, X., Zhao, Q., Li, H., Qin, R., Zuo, W., & Han, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1828376 · Cited by 1
Shukla, K., Castro, J., Cheng, D., Holley, L., & Brunk, E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.05.723010
Oka, S., Huang, C.-Y., Matsushita, M., Titus, A. S., Nakada, Y., Mukai, R., Veera, S., Mourad, Y., Yehia, G., Romanienko, P. J., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.204132
Nicola, M. A., Hefny, F. H., Morsy, R. M. I., Abdel‐Maksoud, F. M., Gamea, M. G., & Hamdy, M. M. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.104956
Jusuf, A. A., Fadilah, & Nirwanti, N. A. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102290
A review on Nrf2 and antioxidant metalloproteins
Hossain, A. M. S., Qudratovna, Q. M., Kholnazarov, B., Odaka, A., Nakane, D., & Akitsu, T. (2026) · European Journal of Chemistry · doi:10.5155/eurjchem.17.2.176-187.2773
Evaluation of the Nrf2-Keap1 Pathway in Patients with Acute Cerebral Ischemic Disease
Alkan, G., Koçtürk, F., Karakus, A., Taysi, M. E., & Tayşi, S. (2026) · Medicina · doi:10.3390/medicina62071371
Baek, S., Miao, Y., Cao, L., Chun, O. K., & Lee, S. G. (2026) · Journal of Food Measurement & Characterization · doi:10.1007/s11694-026-04697-w
Xu, Z., Matsui, C., Septianastiti, M. A., Puspitasari, F., Deng, L., Abe, T., & Shoji, I. (2026) · Microbiology and Immunology · doi:10.1111/1348-0421.70077
Tong, X., Xue, J., Chen, Z., Luo, R., Huang, Z., Chen, F., Liu, Y., Xiao, J., Jiang, J., Wang, Z., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112760
Zhao, H.-Z., Chang, Y.-L., Wang, C., He, Y.-Y., Zhao, Y., Dong, Y.-C., Huang, X.-X., & Zhong, G.-F. (2026) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2026.111620
Zhang, H., Wang, Y., Deng, T., Peng, J., Ye, X., Zeng, X., Zhu, J., Huang, L., Zheng, X., Li, Y., et al. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.08.029
Masci, I., Lezón, C. E., Kurtz, M., & Tasat, D. R. (2026) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2026.105138
Paul, S., Roy, A., Bhattacharya, P., Boruah, D. C., & Borah, A. (2026) · Current Pharmacology Reports · doi:10.1007/s40495-026-00474-x
Liu, X., Sun, J., Mao, C., Cao, Y., Deng, Q., & Li, G.-Y. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05707-7
Irfan, M., Taha, M., Asghar, S. M. F., & Raza, M. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.71091
Ezerioha, C. E., Uahomo, P. O., Chidi-Ezerioha, P. A., Akpan, G. W., & Chukundah, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1907919
Oxidative Stress in Animals: A Systematic Analysis from Signaling Pathways to Biological Effects
Chang, L., Liu, C., & Huang, G. (2026) · Life · doi:10.3390/life16091516
Matić, A., Šupljika, F., Petohleb, L., Paić, A. T., Kindl, D. C., Horvat, G., Barbarić, L., Oskomić, M., Matovina, M., & Tomić, A. (2026) · RSC Advances · doi:10.1039/d6ra05272j
Dual promoter architecture of NFE2L2 underlies isoform-specific translational control of NRF2
Sznarkowska, A., Urban-Wójciuk, Z., Dziadosz-Brzezińska, A., Cieśla, M., Kusiński, S., Wakimian, K., Szabelska-Beręsewicz, A., Chruściel, E., Papak, I., Marek-Trzonkowska, N., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104405
Choi, H. Y., Kwon, H., & Hah, Y. (2026) · Antioxidants · doi:10.3390/antiox15101223
Guangduo, H. A. N., Xinlong, L. I., Zhuang, F., Liu, S., Wentao, Z. H. U., Wei, F. A. N. G., 童加冰, & Wang, D. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122438
Wu, C., Feng, Y., Zhou, Y., Zhu, X., Dai, Q., Ye, Z., & Dong, Z. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.104045
Borba, A. L. T., Freschi, K., Miorando, D., Maccagnan, J. C., Steffler, A. M., Vecchia, C. A. D., Buzatto, M. V., Giacomelli, I. R., Dentz, A. L. V., Marcelino, A. P. N., et al. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122484
Cheng, H., Chen, N., Yang, S.-N., Li, P.-J., Jean, Y.-H., Shih, P., Huang, S.-Y., Chen, W.-F., Sung, C.-S., & Wen, Z.-H. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106272
Campbell, S., O’Reilly, R., Ahmed, O., McElheron, M., Chapman, W. C., & O’Farrelly, C. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.10.038
BindingDB Entry 50001567: Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin.
BindingDB (2020) · UC San Diego · doi:10.7270/q2qc0629
BindingDB Entry 50018333: Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors.
BindingDB (2024) · UC San Diego · doi:10.7270/q2b85dbt
Lalichatsakul, C., Phatthapong, P., Pengrattanachot, N., Sutthasupha, P., Laorodphun, P., Nakrat, S., Sookwong, P., Mahatheeranont, S., & Lungkaphin, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219462
NRF2 in hypertrophic scarring: A stage-dependent redox hub poised between resolution and persistence
Thangboonjit, W., Pluempreecha, M., Soingam, T., & Panich, U. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104460
The Origins of Allergy: An Outside‐In, Bioenergetic Hypothesis
Smith, P. K., West, N. P., Preez, S. D., Sampson, H. A., Hellings, P. W., Price, D. B., O’Mahony, L., Venter, C., Akdiş, C. A., & Yosipovitch, G. (2026) · Allergy · doi:10.1111/all.70532
Metadata
- Authors
- Suzuki, T., & Yamamoto, M.
- Affiliations
- Tohoku University (JP)
- Corresponding author
- Yamamoto, Masayuki
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 88
- Issue
- Pt B
- Pages
- 93-100
- ISSN
- 0891-5849 (ISSN-L)
- OpenAlex
- W952491933
- Cited by
- 995
- References
- 84
- Citations by year
- 2026: 62 · 2025: 89 · 2024: 83 · 2023: 102 · 2022: 116 · 2021: 104 · 2020: 118 · 2019: 88 · 2018: 78 · 2017: 82 · 2016: 62 · 2015: 10
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 360 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Free Radical Biology and Medicine (acceptedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science (26460354, 2611010, 24249015, 25112502)
- Takeda Science Foundation
- Naito Foundation
- Core Research for Evolutional Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Keap1, Nrf2, oxidative stress sensing, electrophilic stress, chemoresistance, carcinogenesis, Nrf2 inhibitors, Nrf2 inducers, therapeutic target
- MeSH terms
- Animals, Humans, Signal Transduction, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review